Last C$0.49 CAD
Change Today +0.01 / 2.08%
Volume 180.3K
LMD On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
As of 3:59 PM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

led medical diagnostics inc (LMD) Snapshot

Open
C$0.49
Previous Close
C$0.48
Day High
C$0.49
Day Low
C$0.48
52 Week High
01/10/14 - C$0.59
52 Week Low
08/22/13 - C$0.34
Market Cap
37.9M
Average Volume 10 Days
235.7K
EPS TTM
--
Shares Outstanding
77.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for LED MEDICAL DIAGNOSTICS INC (LMD)

Related News

No related news articles were found.

led medical diagnostics inc (LMD) Related Businessweek News

No Related Businessweek News Found

led medical diagnostics inc (LMD) Details

LED Medical Diagnostics Inc. is engaged in the development and commercialization of medical devices for the detection and treatment of disease in human tissues primarily in North America. It provides Velscope Vx, an enhanced oral assessment system to screen for oral mucosal tissue anomalies, including early stage oral cancer and pre-cancer. LED Medical Diagnostics, Inc. has an agreement with BC Cancer Agency to create and commercialize a progression-risk assessment test for oral cancer. The company was founded in 2003 and is headquartered in Burnaby, Canada.

28 Employees
Last Reported Date: 05/30/14
Founded in 2003

led medical diagnostics inc (LMD) Top Compensated Officers

Chief Executive Officer and President
Total Annual Compensation: $50.3K
Founder, Chief Science Officer and Director
Total Annual Compensation: $286.4K
Director of Finance
Total Annual Compensation: $46.5K
President of Led Dental Ltd
Total Annual Compensation: $55.0K
Compensation as of Fiscal Year 2013.

led medical diagnostics inc (LMD) Key Developments

LED Medical Diagnostics, Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2014

LED Medical Diagnostics, Inc. announced Consolidated earnings results for the first quarter ended March 31, 2014. The company reported revenue of $1,054,886 for the three months ended March 31, 2014 as compared to $309,590 for the three months ended March 31, 2013. Operating loss was $1,206,789 as compared to a net loss of $1,286,849 for the three months ended March 31, 2014. EBITDA was negative $1,005,363 compared to negative $638,297 for the three months ended March 31, 2013. Net loss before income taxes was $2,893,999 as compared to $1,331,076 for the three months ended March 31, 2013. Net loss and comprehensive loss was $2,893,999 or $0.04 per basic and diluted share as compared to $1,333,774 or $0.03 per basic and diluted share for the three months ended March 31, 2013. Cash flows used in operating activities were $1,310,748 as compared to $362,091 for the three months ended March 31, 2013. Purchase of equipment was $27,171 as compared to nil for the three months ended March 31, 2013.

LED Medical Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt

LED Medical Diagnostics, Inc. filed its Annual on Apr 15, 2014 for the period ending Dec 31, 2013. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

LED Medical Diagnostics Inc. Announces Audited Consolidated Financial Results for the Fourth Quarter and Full Year Ended December 31, 2013

LED Medical Diagnostics Inc. announced audited consolidated financial results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported revenues were $215,714 compared to $1,389,994 a year ago. Operating loss was $1,717,791 compared to $98,063 a year ago. Net loss and comprehensive loss before income taxes was $1,452,854 compared to $174,540 a year ago. Net loss and comprehensive loss for the year was $1,460,801 compared to $174,540 a year ago. Cash flows used in operating activities was $828,053 compared to $502,271 a year ago. Purchase of equipment was $4,664 compared to $4,098 a year ago. LBITDA was $1,238,255 compared to $83,502 for the three months ended December 31, 2012. For the year, the company reported revenues were $2,519,574 compared to $6,312,754 a year ago. Operating loss was $3,640,885 compared to $787,911 a year ago. Net loss and comprehensive loss before income taxes was $6,943,171 compared to $854,093 a year ago. Net loss and comprehensive loss for the year was $6,955,217 compared to $866,933 a year ago. Cash flows used in operating activities was $3,060,948 compared to $982,679 a year ago. Purchase of equipment was $7,731 compared to $16,758 a year ago. LBITDA was $2,120,231, as compared to $728,135 for the year ended December 31, 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMD:CN C$0.49 CAD +0.01

LMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LMD.
View Industry Companies
 

Industry Analysis

LMD

Industry Average

Valuation LMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LED MEDICAL DIAGNOSTICS INC, please visit www.velscope.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.